A unique treatment for breast cancer: laser surgery In 2016 almost 300,000 women will be diagnosed with breast cancer. Treatments for women vary from case to case, but Dr. Vincent Ansanelli, a surgeon in Long Island, New York offers an option many may not know about, laser breast cancer surgery
Cancer survivor receives world's first 3-D printed face prosthesis A 54-year-old man whose face was ravaged by a tumor has been given the first-ever face prosthesis created with 3D printing technology.
Palliative care should be standard in cancer treatment: guideline For patients with advanced cancer, palliative care should start early and be an integral part of treatment, not just something added on near the end of life, according to a new practice guideline from the American Society for Clinical Oncology (ASCO).
Father shares photo of daughter near end of cancer battle to raise awareness On Oct. 27, doctors at Royal Manchester Children’s Hospital informed 4-year-old Jessica Whelan’s parents that she would only have weeks left to live.
Community rallies around orphaned teen who gave up football to manage household A high school senior who gave up football following the death of his parents is getting some financial help from his Minnesota community as he struggles to care for his family and maintain their household.
Cheap cancer measures could save hundreds of thousands of lives in poor countries Health interventions costing as little as $1.72 per person could prevent hundreds of thousands of deaths from breast and cervical cancer in developing countries, scientists said on Tuesday.
Parents blame bullying after 11-year-old cancer survivor commits suicide Eight years ago, Bethany Thompson battled brain cancer and the removal of a tumor damaged her nerves and left her with a off-center smile.
Costs keep women from taking drugs to prevent cancer's return Poverty and higher out-of-pocket drug costs may be the main reason that some women don't stick with hormone therapy designed to prevent breast cancer from coming back, a recent U.S. study suggests.
Novartis breast cancer drug gets FDA fast track, takes on Pfizer The U.S. Food and Drug Administration gave fast-track review status to Novartis's medication ribociclib in first-line treatment of postmenopausal women with advanced breast cancer as the Swiss company seeks to challenge Pfizer's Ibrance drug.
